在糖尿病并发症的发展中作为调节者的LncRNA
Mengrou Geng1,2, Wei Liu2, Jinjie Li2
1Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University and College of Basic Medical Science, Jilin University, Changchun, China.
Frontiers in endocrinology
|February 23, 2024
概括
长非编码RNAs (lncRNAs) 涉及糖尿病并发症,如腎病和视网膜病. 失调的lncRNAs有助于病变发生,并可能成为糖尿病的未来治疗点.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 糖尿病是一种以高血糖症为标志的代谢障碍,导致先进的糖化终产物 (AGEs),活性氧物种 (ROS) 和炎症.
- 这些病理途径有助于血管功能障碍和目标器官损伤,表现为常见的糖尿病并发症,如腎病,视网膜病和心肌病.
- 长非编码RNAs (lncRNAs) 是基因表达的关键调节者,影响转录,mRNA稳定性和翻译,并且已经成为疾病发病的重要参与者.
研究的目的:
- 审查长非编码RNAs (lncRNAs) 在糖尿病并发症的主要致病机制中的调节作用.
- 探索lncRNAs在与糖尿病相关的氧化应激,炎症,纤维化和微血管功能障碍中的参与.
- 为了确定潜在的 lncRNAs,可以作为生物标志物或治疗目标来管理糖尿病并发症.
主要方法:
- 文献综述和现有关于 lncRNAs 和糖尿病并发症的研究的综合.
- 分析详细介绍 lncRNAs 影响糖尿病病变的分子机制的研究.
- 确定和讨论关键病理过程中涉及的特定 lncRNAs.
主要成果:
- 失调的lncRNAs广泛参与糖尿病并发症的发病.
- lncRNAs调节关键路径,包括氧化应激,炎症,纤维化和微血管功能障碍.
- 特定的lncRNA被确定为糖尿病并发症的发展和进展的潜在贡献者.
结论:
- 长非编码RNA在糖尿病并发症的发展和进展中起着重要作用.
- lncRNAs为开发新型诊断生物标志物和糖尿病并发症治疗策略提供了有前途的途径.
- 对糖尿病中lncRNA功能的进一步研究是有必要的,以将这些发现转化为临床应用.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:19Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:54Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K